[Endocrine disease:progress in diagnosis and treatment. Topics: II. Progress in treatment; 6. Renin-angiotensin-aldosterone inhibition in the medical treatment of primary aldosteronism].
Department of Medicine, Institute of Clinical Endocrinology and Hypertension, Tokyo Women's Medical University, Japan.
Akiyo
A
Tanabe
Atsuhiro
A
Ichihara
D002121:Calcium Channel Blockers / Q000627:therapeutic use; D006801:Humans; D006929:Hyperaldosteronism / Q000188:drug therapy*; D000451:Mineralocorticoid Receptor Antagonists; D012084:Renin-Angiotensin System / Q000187:drug effects
D002121:Calcium Channel Blockers; D000451:Mineralocorticoid Receptor Antagonists